The relationship between potential categories of self-management behavior and disease knowledge level of gout patients based on K-means clustering analysis

Gout, a painful and increasingly prevalent inflammatory joint disease driven by the crystallization of monosodium urate in and around the joints, continues to present a major global public health challenge. With more than 9.4 million new cases annually and a global population of nearly 57 million patients affected, medical researchers are shifting their focus from broad, generalized treatment models toward personalized, patient-centered care. While effective urate-lowering therapies exist, poor treatment adherence and widespread gaps in disease understanding have left millions struggling with suboptimal disease control.

Addressing this critical gap, a recent study published in Frontiers in Psychology utilized K-means cluster analysis to examine the heterogeneous nature of self-management behaviors among gout patients. The research, conducted between October 2025 and June 2026 at a tertiary hospital in Guangdong Province, highlights how patient behavior and disease literacy intersect, offering a framework for clinicians to deploy stratified, precise medical interventions.

Uncovering the Patient Subgroups

To capture a comprehensive view of patient habits, researchers surveyed 402 gout patients using a convenience sampling method. Participants completed a general information questionnaire, a gout-specific knowledge measurement quiz, and a detailed self-management assessment scale divided into four core dimensions: disease treatment management, diet management, lifestyle management, and psychosocial management.

Using rigorous statistical validation, including the elbow method and convergence stability tests, the research team categorized the cohort into four distinct behavioral and cognitive profiles. This classification revealed deep structural differences within the patient population that standard, one-size-fits-all health education campaigns typically overlook.

1. High Self-Management-Knowledge Adequacy Type (28.6%): Patients in this group exhibited the highest overall self-management scores (176.06 ± 14.11) and the highest disease knowledge reserves. They successfully translated their robust understanding of gout into comprehensive daily care.
2. Low Self-Management-Knowledge Deficiency Type (15.4%): Representing the most vulnerable cohort, these patients scored lowest across all self-management dimensions (95.63 ± 13.90) and possessed severe knowledge deficits. High serum uric acid levels and frequent acute flares characterized this group, placing them at extreme risk for uncontrolled disease progression.
3. Moderate Self-Management-Insufficient Transformation Type (30.8%): Comprising the largest single subgroup, these patients possessed a moderate understanding of gout yet struggled to put that knowledge into practice. Their profile highlights a distinct "knowledge-behavior gap," where awareness fails to translate into effective lifestyle changes.
4. Good Self-Management-Knowledge Deficiency Type (25.1%): Exhibiting an inverse pattern to the third group, these patients maintained relatively high behavioral compliance despite having lower formal knowledge reserves, potentially relying on external routines or structured medical cues rather than internal cognitive mastery.

The Role of Disease Knowledge and Clinical Variables

The study’s findings underscore disease knowledge as a core differentiating factor among gout sufferers. Overall, the cohort demonstrated a low average disease knowledge score of 5.71 out of 10, with an overall awareness rate of just 35.1%. Psychosocial management emerged as a universal weak point across multiple subgroups, highlighting how chronic pain, stigma, and passive coping mechanisms undermine long-term recovery.

Multivariate logistic regression analysis further identified key demographic and clinical variables associated with these behavioral profiles. Factors such as patient age, geographic residence, frequency of acute flare-ups over the past year, and serum uric acid (SUA) levels played a statistically significant role in determining a patient’s category.

Notably, rural residents faced significantly higher risks of falling into unmanaged or deficient categories compared to their urban counterparts, reflecting broader disparities in healthcare resource distribution and health literacy outreach. Furthermore, patients experiencing more than three acute flare-ups annually were nearly eight times more likely to belong to the low self-management-knowledge deficiency group, trapping them in a vicious cycle of physical pain and behavioral paralysis. Elevated SUA levels (>520 µmol/L) similarly correlated with poorer behavioral alignment and inadequate disease control.

Implications for Precision Healthcare and Future Interventions

The clinical implications of this research point toward an urgent need for stratified, precision-based healthcare models. Traditional health education approaches—which treat patients as a uniform demographic—frequently fail to address the specific deficits holding individual sufferers back.

Medical experts suggest that intervention strategies must be tailored to the distinct needs of each subgroup. For patients with high knowledge adequacy, clinical focus should center on routine follow-ups, positive behavioral reinforcement, and leveraging their success as peer mentors. Conversely, high-risk groups characterized by knowledge deficits and frequent flares require simplified, accessible educational tools, behavioral contracts, and structured medication monitoring programs to rebuild confidence and compliance.

For those trapped in the "knowledge-behavior gap," clinicians must prioritize attitude transformation, health belief restructuring, and psychosocial support to bridge the divide between knowing what to do and actually executing it.

While the study is bounded by limitations such as its single-center design and cross-sectional methodology, its findings provide a vital roadmap for future longitudinal and multi-center research. By acknowledging the complex psychological, behavioral, and educational diversity of gout patients, healthcare providers can move closer to sustainable, individualized disease management that ultimately reduces flare frequency, lowers uric acid levels, and improves long-term patient outcomes.